LBO — BAYSHORE MEDICAL CENTER
IRR: 33.8% | MOIC: 4.29x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
33.8%
IRR
4.29x
MOIC
$41.1M
Entry EV
$110.6M
Exit EV
$21.2M
Equity Invested
Sources & Uses
S&UTotal · $41.1M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $16.0M | 38.8% | |
| Sub Debt | $4.0M | 9.7% | |
| Equity | $21.2M | 51.5% | |
| Enterprise Value | $39.9M | 97.1% | |
| Transaction Fees | $1.2M | 2.9% | |
| Total Uses | $41.1M | 100.0% |
Interpretation
INTAt 4.29x MOIC and 33.8% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $10.5M |
| Exit Ev | $110.6M |
| Net Debt At Exit | $20.0M |
| Equity At Exit | $90.7M |
| Equity Invested | $21.2M |
| Total Value Created | $69.5M |
| Value From Growth | $68.7M |
| Value From Multiple | $2.0M |
| Value From Deleveraging | 0.0% |